Literature DB >> 18513322

Inflammatory pain is enhanced in delta opioid receptor-knockout mice.

Claire Gavériaux-Ruff1, Laurie A Karchewski, Xavier Hever, Audrey Matifas, Brigitte L Kieffer.   

Abstract

To examine the involvement of opioid receptors in inflammatory pain, we compared Complete Freund's Adjuvant-induced hyperalgesia in mice lacking mu, delta or kappa receptors under the same experimental conditions. Mechanical allodynia and thermal hyperalgesia were measured using von Frey filaments and the plantar test, respectively. All three receptor-knockout mice, as well as wild-type animals, developed inflammatory hyperalgesia following Complete Freund's Adjuvant administration. Mu-receptor mutants showed similar hyperalgesia to wild-types in the two tests. Kappa-receptor mutants exhibited enhanced mechanical allodynia compared with wild-type mice but similar thermal hyperalgesia. In contrast, mechanical allodynia and thermal hyperalgesia were both markedly augmented in delta-receptor mutants, indicating a role for an endogenous delta-receptor tone in the control of inflammatory pain. Treatment with the delta-selective agonist SNC80 produced antihyperalgesia, and this effect was abolished in the delta-receptor knockout mice. Altogether, these data demonstrate that delta receptors inhibit inflammatory pain when activated either endogenously or exogenously. We have previously shown enhanced neuropathic pain in delta-receptor knockout mice. The delta receptor definitely represents a promising target for treating chronic pain conditions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18513322      PMCID: PMC4445739          DOI: 10.1111/j.1460-9568.2008.06223.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  62 in total

Review 1.  Attacking pain at its source: new perspectives on opioids.

Authors:  Christoph Stein; Michael Schäfer; Halina Machelska
Journal:  Nat Med       Date:  2003-08       Impact factor: 53.440

2.  Delta-opioid receptor agonist SNC80 induces peripheral antinociception via activation of ATP-sensitive K+ channels.

Authors:  Daniela F Pacheco; Igor D G Duarte
Journal:  Eur J Pharmacol       Date:  2005-04-04       Impact factor: 4.432

3.  Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50,488H and attenuates morphine withdrawal.

Authors:  F Simonin; O Valverde; C Smadja; S Slowe; I Kitchen; A Dierich; M Le Meur; B P Roques; R Maldonado; B L Kieffer
Journal:  EMBO J       Date:  1998-02-16       Impact factor: 11.598

Review 4.  Exploring the opioid system by gene knockout.

Authors:  Brigitte L Kieffer; Claire Gavériaux-Ruff
Journal:  Prog Neurobiol       Date:  2002-04       Impact factor: 11.685

5.  Beta-endorphin, Met-enkephalin and corresponding opioid receptors within synovium of patients with joint trauma, osteoarthritis and rheumatoid arthritis.

Authors:  Shaaban A Mousa; Rainer H Straub; Michael Schäfer; Christoph Stein
Journal:  Ann Rheum Dis       Date:  2007-02-26       Impact factor: 19.103

6.  Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain.

Authors:  Shaaban A Mousa; Halina Machelska; Michael Schäfer; Christoph Stein
Journal:  J Neuroimmunol       Date:  2002-05       Impact factor: 3.478

7.  Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones.

Authors:  Miquel Martin; Audrey Matifas; Rafael Maldonado; Brigitte L Kieffer
Journal:  Eur J Neurosci       Date:  2003-02       Impact factor: 3.386

8.  Characterization of mechanical withdrawal responses and effects of mu-, delta- and kappa-opioid agonists in normal and mu-opioid receptor knockout mice.

Authors:  P N Fuchs; C Roza; I Sora; G Uhl; S N Raja
Journal:  Brain Res       Date:  1999-03-13       Impact factor: 3.252

9.  Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue.

Authors:  A H Hassan; A Ableitner; C Stein; A Herz
Journal:  Neuroscience       Date:  1993-07       Impact factor: 3.590

10.  Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue.

Authors:  Waltraud Binder; Shaaban A Mousa; Nicolle Sitte; Myriam Kaiser; Christoph Stein; Michael Schäfer
Journal:  Eur J Neurosci       Date:  2004-07       Impact factor: 3.386

View more
  52 in total

1.  A PTEN-Regulated Checkpoint Controls Surface Delivery of δ Opioid Receptors.

Authors:  Daniel J Shiwarski; Alycia Tipton; Melissa D Giraldo; Brigitte F Schmidt; Michael S Gold; Amynah A Pradhan; Manojkumar A Puthenveedu
Journal:  J Neurosci       Date:  2017-03-06       Impact factor: 6.167

Review 2.  Ligand-directed signalling within the opioid receptor family.

Authors:  Amynah A Pradhan; Monique L Smith; Brigitte L Kieffer; Christopher J Evans
Journal:  Br J Pharmacol       Date:  2012-11       Impact factor: 8.739

Review 3.  Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.

Authors:  Claire Gavériaux-Ruff; Brigitte Lina Kieffer
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

4.  Effect of transdermal opioids in experimentally induced superficial, deep and hyperalgesic pain.

Authors:  T Andresen; C Staahl; A Oksche; H Mansikka; L Arendt-Nielsen; A M Drewes
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 5.  Molecular and cellular mechanisms that initiate pain and itch.

Authors:  Jialie Luo; Jing Feng; Shenbin Liu; Edgar T Walters; Hongzhen Hu
Journal:  Cell Mol Life Sci       Date:  2015-04-18       Impact factor: 9.261

6.  The mixed kappa and delta opioid receptor agonist, MP1104, attenuates chemotherapy-induced neuropathic pain.

Authors:  Diana Vivian Atigari; Kelly Frances Paton; Rajendra Uprety; András Váradi; Amy Frances Alder; Brittany Scouller; John H Miller; Susruta Majumdar; Bronwyn Maree Kivell
Journal:  Neuropharmacology       Date:  2020-12-28       Impact factor: 5.250

7.  Effects of the δ opioid receptor agonist SNC80 on pain-related depression of intracranial self-stimulation (ICSS) in rats.

Authors:  S Stevens Negus; Marisa B Rosenberg; Ahmad A Altarifi; Robert H O'Connell; John E Folk; Kenner C Rice
Journal:  J Pain       Date:  2012-03-15       Impact factor: 5.820

8.  Implication of delta opioid receptor subtype 2 but not delta opioid receptor subtype 1 in the development of morphine analgesic tolerance in a rat model of chronic inflammatory pain.

Authors:  H Beaudry; L Gendron; J A Morón
Journal:  Eur J Neurosci       Date:  2015-01-09       Impact factor: 3.386

9.  Mu-opioid receptors are not necessary for nortriptyline treatment of neuropathic allodynia.

Authors:  Yohann Bohren; Dzenan Karavelic; Luc-Henri Tessier; Ipek Yalcin; Claire Gavériaux-Ruff; Brigitte L Kieffer; Marie-José Freund-Mercier; Michel Barrot
Journal:  Eur J Pain       Date:  2009-12-28       Impact factor: 3.931

10.  GRK2 Constitutively Governs Peripheral Delta Opioid Receptor Activity.

Authors:  Allison Doyle Brackley; Ruben Gomez; Armen N Akopian; Michael A Henry; Nathaniel A Jeske
Journal:  Cell Rep       Date:  2016-08-25       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.